These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 9050832)

  • 1. Persistence in muscle of an adenoviral vector that lacks all viral genes.
    Chen HH; Mack LM; Kelly R; Ontell M; Kochanek S; Clemens PR
    Proc Natl Acad Sci U S A; 1997 Mar; 94(5):1645-50. PubMed ID: 9050832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo muscle gene transfer of full-length dystrophin with an adenoviral vector that lacks all viral genes.
    Clemens PR; Kochanek S; Sunada Y; Chan S; Chen HH; Campbell KP; Caskey CT
    Gene Ther; 1996 Nov; 3(11):965-72. PubMed ID: 8940636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adeno-associated virus vector-mediated gene transfer into dystrophin-deficient skeletal muscles evokes enhanced immune response against the transgene product.
    Yuasa K; Sakamoto M; Miyagoe-Suzuki Y; Tanouchi A; Yamamoto H; Li J; Chamberlain JS; Xiao X; Takeda S
    Gene Ther; 2002 Dec; 9(23):1576-88. PubMed ID: 12424610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ex vivo gene transfer using adenovirus-mediated full-length dystrophin delivery to dystrophic muscles.
    Floyd SS; Clemens PR; Ontell MR; Kochanek S; Day CS; Yang J; Hauschka SD; Balkir L; Morgan J; Moreland MS; Feero GW; Epperly M; Huard J
    Gene Ther; 1998 Jan; 5(1):19-30. PubMed ID: 9536261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stable micro-dystrophin gene transfer using an integrating adeno-retroviral hybrid vector ameliorates the dystrophic pathology in mdx mouse muscle.
    Roberts ML; Wells DJ; Graham IR; Fabb SA; Hill VJ; Duisit G; Yuasa K; Takeda S; Cosset FL; Dickson G
    Hum Mol Genet; 2002 Jul; 11(15):1719-30. PubMed ID: 12095914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic gene transfer to dystrophic diaphragm by an adenoviral vector deleted of all viral genes.
    Matecki S; Dudley RW; Divangahi M; Gilbert R; Nalbantoglu J; Karpati G; Petrof BJ
    Am J Physiol Lung Cell Mol Physiol; 2004 Sep; 287(3):L569-76. PubMed ID: 15155269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA from both high-capacity and first-generation adenoviral vectors remains intact in skeletal muscle.
    Chen HH; Mack LM; Choi SY; Ontell M; Kochanek S; Clemens PR
    Hum Gene Ther; 1999 Feb; 10(3):365-73. PubMed ID: 10048389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune response to full-length dystrophin delivered to Dmd muscle by a high-capacity adenoviral vector.
    Gilchrist SC; Ontell MP; Kochanek S; Clemens PR
    Mol Ther; 2002 Sep; 6(3):359-68. PubMed ID: 12231172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CTLA4Ig delivered by high-capacity adenoviral vector induces stable expression of dystrophin in mdx mouse muscle.
    Jiang Z; Schiedner G; Gilchrist SC; Kochanek S; Clemens PR
    Gene Ther; 2004 Oct; 11(19):1453-61. PubMed ID: 15269713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dystrophin delivery in dystrophin-deficient DMDmdx skeletal muscle by isogenic muscle-derived stem cell transplantation.
    Ikezawa M; Cao B; Qu Z; Peng H; Xiao X; Pruchnic R; Kimura S; Miike T; Huard J
    Hum Gene Ther; 2003 Nov; 14(16):1535-46. PubMed ID: 14577915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained muscle expression of dystrophin from a high-capacity adenoviral vector with systemic gene transfer of T cell costimulatory blockade.
    Jiang Z; Schiedner G; van Rooijen N; Liu CC; Kochanek S; Clemens PR
    Mol Ther; 2004 Oct; 10(4):688-96. PubMed ID: 15451453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Full-length dystrophin gene transfer to the mdx mouse in utero.
    Reay DP; Bilbao R; Koppanati BM; Cai L; O'Day TL; Jiang Z; Zheng H; Watchko JF; Clemens PR
    Gene Ther; 2008 Apr; 15(7):531-6. PubMed ID: 18273052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Herpes simplex virus VP22 enhances adenovirus-mediated microdystrophin gene transfer to skeletal muscles in dystrophin-deficient (mdx) mice.
    Xiong F; Xiao S; Peng F; Zheng H; Yu M; Ruan Y; Li W; Shang Y; Zhao C; Zhou W; Chen H; Chamberlain JS; Fang L; Zhang C
    Hum Gene Ther; 2007 Jun; 18(6):490-501. PubMed ID: 17550336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged dystrophin expression and functional correction of mdx mouse muscle following gene transfer with a helper-dependent (gutted) adenovirus-encoding murine dystrophin.
    Gilbert R; Dudley RW; Liu AB; Petrof BJ; Nalbantoglu J; Karpati G
    Hum Mol Genet; 2003 Jun; 12(11):1287-99. PubMed ID: 12761044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The spread of transgene expression at the site of gene construct injection.
    O'Hara AJ; Howell JM; Taplin RH; Fletcher S; Lloyd F; Kakulas B; Lochmüller H; Karpati G
    Muscle Nerve; 2001 Apr; 24(4):488-95. PubMed ID: 11268020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new adenoviral vector: Replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and beta-galactosidase.
    Kochanek S; Clemens PR; Mitani K; Chen HH; Chan S; Caskey CT
    Proc Natl Acad Sci U S A; 1996 Jun; 93(12):5731-6. PubMed ID: 8650161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of high-capacity and first-generation adenoviral vector gene delivery to murine muscle in utero.
    Bilbao R; Reay DP; Wu E; Zheng H; Biermann V; Kochanek S; Clemens PR
    Gene Ther; 2005 Jan; 12(1):39-47. PubMed ID: 15483668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transient immunosuppression by FK506 permits a sustained high-level dystrophin expression after adenovirus-mediated dystrophin minigene transfer to skeletal muscles of adult dystrophic (mdx) mice.
    Lochmüller H; Petrof BJ; Pari G; Larochelle N; Dodelet V; Wang Q; Allen C; Prescott S; Massie B; Nalbantoglu J; Karpati G
    Gene Ther; 1996 Aug; 3(8):706-16. PubMed ID: 8854096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustained improvement of muscle function one year after full-length dystrophin gene transfer into mdx mice by a gutted helper-dependent adenoviral vector.
    Dudley RW; Lu Y; Gilbert R; Matecki S; Nalbantoglu J; Petrof BJ; Karpati G
    Hum Gene Ther; 2004 Feb; 15(2):145-56. PubMed ID: 14975187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunology of gene therapy with adenoviral vectors in mouse skeletal muscle.
    Yang Y; Haecker SE; Su Q; Wilson JM
    Hum Mol Genet; 1996 Nov; 5(11):1703-12. PubMed ID: 8922997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.